Daniel Shevrin to Hypercalcemia
This is a "connection" page, showing publications Daniel Shevrin has written about Hypercalcemia.
Connection Strength
0.296
-
Effect of epidermal growth factor infusion on serum and urine calcium in mice. J Bone Miner Res. 1987 Aug; 2(4):297-301.
Score: 0.076
-
Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium. Clin Pharm. 1985 Mar-Apr; 4(2):204-5.
Score: 0.064
-
Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer. Endocrinology. 1990 Jul; 127(1):305-10.
Score: 0.023
-
Effects of hypercalcemia-producing tumor extract and parathyroid hormone on osteoclast ultrastructure. Acta Anat (Basel). 1990; 137(2):160-4.
Score: 0.022
-
Effect of hypercalcemia-producing tumor on 1,25(OH)2D3 biosynthesis in athymic mice. Am J Physiol. 1989 Feb; 256(2 Pt 1):E309-14.
Score: 0.021
-
Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors. J Clin Invest. 1988 Nov; 82(5):1798-802.
Score: 0.021
-
Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy. J Bone Miner Res. 1988 Oct; 3(5):555-60.
Score: 0.020
-
Treatment of cancer-associated hypercalcemia with cisplatin. Arch Intern Med. 1987 Feb; 147(2):329-32.
Score: 0.018
-
Cis-platinum treatment for malignancy-associated humoral hypercalcemia in an athymic mouse model. Calcif Tissue Int. 1984 Sep; 36(5):559-62.
Score: 0.015
-
A model for malignancy-associated humoral hypercalcemia. Calcif Tissue Int. 1984 Sep; 36(5):563-7.
Score: 0.015